Shares in AstraZeneca and Ionis Pharmaceuticals tumbled after reporting their Wainua drug failed to meet the primary target in a heart disease trial

6 hours ago 1

The drugmakers said the cause didn’t conscionable its superior nonsubjective successful a Phase 3 proceedings erstwhile treating a uncommon benignant of bosom disease.

Read Entire Article

Shares in AstraZeneca and Ionis Pharmaceuticals tumbled after reporting their Wainua drug failed to meet the primary target in a heart disease trial

Related

Why women suffer more in the heat

Will ice cream or chilli cool you down?

Ebola deaths in Congo reach 600; new cases suspected in prev...

Popular

Turkish comedian arrested for 'insulting' Islam and Erdogan

Toronto hosts its last game. Portugal versus Croatia is a gr...

A grand jury indicts Louisiana's attorney general in a fight...

Trump got the Senate candidates he wanted. How much will he ...

A-listers, phone bans, charity donations: Taylor Swift and T...